Fidelity Investments’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
SCM
FLAM
VCM
Fidelity Investments's ORGO Position: Q1 2026 in Review
Fidelity Investments increased its Organogenesis Holdings (ORGO) stake by 41% in Q1 2026, buying an estimated $380K and bringing the position to 375,815 shares worth $891K. The position accounts for ﹤0.01% of the portfolio, ranked #2912.
Fidelity Investments first reported a position in ORGO in Q3 2021 and has held it in 19 quarters since. The position peaked at $10.9M in Q3 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.
- Fidelity Investments held 375,815 shares of Organogenesis Holdings worth $891K as of Q1 2026.
- Fidelity Investments bought 109,808 Organogenesis Holdings shares in Q1 2026, an estimated $380K.
- Organogenesis Holdings made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2912 holding.
- Fidelity Investments first reported a position in Organogenesis Holdings in Q3 2021 and has held it in 19 quarters since.
- Fidelity Investments's Organogenesis Holdings position peaked at $10.9M in Q3 2021.
- 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.